Citations (120)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Maria Elisa Rodrigues, Sónia Silva, Joana Azeredo & Mariana Henriques. (2016) Novel strategies to fight Candida species infection. Critical Reviews in Microbiology 42:4, pages 594-606.
Read now
Read now
Annette W Fothergill. (2006) Miconazole: a historical perspective. Expert Review of Anti-infective Therapy 4:2, pages 171-175.
Read now
Read now
Karl A Werbovetz. (2002) Promising therapeutic targets for antileishmanial drugs. Expert Opinion on Therapeutic Targets 6:4, pages 407-422.
Read now
Read now
Edward T Burt. (2001) Current approaches to the treatment of Candida albicans infections. Expert Opinion on Therapeutic Patents 11:2, pages 269-282.
Read now
Read now
MaryBeth Frosco & John F Barrett. (1998) Importance of antifungal drug-resistance: clinical significance and need for novel therapy. Expert Opinion on Investigational Drugs 7:2, pages 175-198.
Read now
Read now
R. M. V. Pallavi, D. Ramana & R. B. Sashidhar. (1997) Synthesis of the antigen bovine serum albumin‐ergosterol and its immunocharacterization. Food and Agricultural Immunology 9:2, pages 85-95.
Read now
Read now
H. Vanden Bossche, D.W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F.C. Odds, F. Provost & O. Ronin. (1994) Mechanisms and clinical impact of antifungal drug resistance. Journal of Medical and Veterinary Mycology 32:sup1, pages 189-202.
Read now
Read now
C. Gil, R. Pérez-Diaz & C. Nombela. (1994) Inhibitory and morphological effects of several antifungal agents on three types of Candida albicans morphological mutants. Journal of Medical and Veterinary Mycology 32:3, pages 151-162.
Read now
Read now
E. Drouhet, B. Dupont, L. Improvisi, M. Lesourd & M.C. Prevost. (1990) Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy. Journal of Medical and Veterinary Mycology 28:6, pages 425-436.
Read now
Read now
Articles from other publishers (111)
Angelica Sharapova, Svetlana Blokhina, Marina Ol'khovich & German Perlovich. (2022) Thermodynamic analysis of solubility, distribution and solvation of antifungal miconazole in relevant pharmaceutical media. Journal of Molecular Liquids 347, pages 118248.
Crossref
Crossref
Doralyn S. Dalisay, Evan W. Rogers & Tadeusz F. Molinski. (2021) Oceanapiside, a Marine Natural Product, Targets the Sphingolipid Pathway of Fluconazole-Resistant Candida glabrata. Marine Drugs 19:3, pages 126.
Crossref
Crossref
Shella Gilbert-Girard, Kirsi Savijoki, Jari Yli-Kauhaluoma & Adyary Fallarero. (2020) Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod. Microorganisms 8:11, pages 1834.
Crossref
Crossref
Rania Hamdy, Bahgat Fayed, Alshaimaa M. Hamoda, Mutasem Rawas-Qalaji, Mohamed Haider & Sameh S. M. Soliman. (2020) Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation. Molecules 25:6, pages 1463.
Crossref
Crossref
Mohd Adil Shareef, Hemshikha Rajpurohit, K. Sirisha, Ibrahim Bin Sayeed, Irfan Khan, Manasa Kadagathur, Thipparapu Ganapathi, C. Ganesh Kumar, Ahmed Kamal & Bathini Nagendra Babu. (2019)
Design, Synthesis and Biological Evaluation of Substituted (1-(4-chlorobenzyl)-1
H
-indol-3-yl) 1
H
-(1,2,3-triazol-4-yl)methanones as Antifungal Agents
. ChemistrySelect 4:8, pages 2258-2266.
Crossref
Crossref
Jose A Reales-Calderón, Gloria Molero, Concha Gil & José L Martínez. (2016) The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies. Future Medicinal Chemistry 8:12, pages 1503-1520.
Crossref
Crossref
Bing Han, Jia Chen, Yi-qun Yu, Yong-bing Cao & Yuan-ying Jiang. (2016)
Antifungal activity of
Rubus chingii
extract combined with fluconazole against fluconazole-resistant
Candida albicans
. Microbiology and Immunology 60:2, pages 82-92.
Crossref
Crossref
M. Sakko, C. Moore, L. Novak-Frazer, V. Rautemaa, T. Sorsa, P. Hietala, A. Järvinen, P. Bowyer, L. Tjäderhane & R. Rautemaa. (2014)
2-hydroxyisocaproic acid is fungicidal for
Candida
and
Aspergillus
species
. Mycoses 57:4, pages 214-221.
Crossref
Crossref
Biao Ren, Huan-Qin Dai, Gang Pei, Yao-Jun Tong, Ying Zhuo, Na Yang, Meng-Yi Su, Pei Huang, Yu-Zhuo Yang & Li-Xin Zhang. (2014) ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility. Applied Microbiology and Biotechnology 98:6, pages 2609-2616.
Crossref
Crossref
Christina Gallo-Ebert, Melissa Donigan, Ilana L. Stroke, Robert N. Swanson, Melissa T. Manners, Jamie Francisco, Geoffrey Toner, Denise Gallagher, Chia-Yu Huang, Scott E. Gygax, Maria Webb & Joseph T. NickelsJr.Jr.. (2014) Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor. Antimicrobial Agents and Chemotherapy 58:1, pages 258-266.
Crossref
Crossref
Aline Koch, Neelendra Kumar, Lennart Weber, Harald Keller, Jafargholi Imani & Karl-Heinz Kogel. (2013)
Host-induced gene silencing of cytochrome P450 lanosterol C14α-demethylase–encoding genes confers strong resistance to
Fusarium
species
. Proceedings of the National Academy of Sciences 110:48, pages 19324-19329.
Crossref
Crossref
Cecília C. P. da Silva, Rebeka de Oliveira, Juan C. Tenorio, Sara B. Honorato, Alejandro P. Ayala & Javier Ellena. (2013) The Continuum in 5-Fluorocytosine. Toward Salt Formation. Crystal Growth & Design 13:10, pages 4315-4322.
Crossref
Crossref
Jessica A. Edwards, Megan M. Kemski & Chad A. Rappleye. (2013) Identification of an Aminothiazole with Antifungal Activity against Intracellular Histoplasma capsulatum. Antimicrobial Agents and Chemotherapy 57:9, pages 4349-4359.
Crossref
Crossref
Zhi-Feng Chen, Guang-Guo Ying, Yi-Bing Ma, Hua-Jie Lai, Feng Chen & Chang-Gui Pan. (2013) Typical Azole Biocides in Biosolid-Amended Soils and Plants Following Biosolid Applications. Journal of Agricultural and Food Chemistry 61:26, pages 6198-6206.
Crossref
Crossref
Stefano Veraldi. (2013) Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids. Mycoses 56, pages 3-15.
Crossref
Crossref
Zhi-Feng Chen, Guang-Guo Ying, Yi-Bing Ma, Hua-Jie Lai, Feng Chen & Chang-Gui Pan. (2013) Occurrence and dissipation of three azole biocides climbazole, clotrimazole and miconazole in biosolid-amended soils. Science of The Total Environment 452-453, pages 377-383.
Crossref
Crossref
Zhi-Feng Chen, Guang-Guo Ying, Hua-Jie Lai, Feng Chen, Hao-Chang Su, You-Sheng Liu, Fu-Qiang Peng & Jian-Liang Zhao. (2012) Determination of biocides in different environmental matrices by use of ultra-high-performance liquid chromatography–tandem mass spectrometry. Analytical and Bioanalytical Chemistry 404:10, pages 3175-3188.
Crossref
Crossref
Lulu Wang, Wenge Yang, Kai Wang, Jing Zhu, Fei Shen & Yonghong Hu. (2012) Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum. Bioorganic & Medicinal Chemistry Letters 22:14, pages 4887-4890.
Crossref
Crossref
Vassilios N. Kotiadis, Jane E. Leadsham, Emma L. Bastow, Aline Gheeraert, Jennafer M Whybrew, Martin Bard, Pekka Lappalainen & Campbell W. Gourlay. (2012) Identification of new surfaces of Cofilin that link mitochondrial function to the control of multi-drug resistance. Journal of Cell Science.
Crossref
Crossref
Aijaz Ahmad, Amber Khan, N. P. Bharathi, Athar Adil Hashmi, Luqman A. Khan & Nikhat Manzoor. (2010) Impaired ergosterol biosynthesis mediated fungicidal activity of oil based tin polymer. Medicinal Chemistry Research 20:8, pages 1141-1146.
Crossref
Crossref
Xiaoyun Chai, Jun Zhang, Yongbing Cao, Yan Zou, Qiuye Wu, Dazhi Zhang, Yuanying Jiang & Qingyan Sun. (2011) New azoles with antifungal activity: Design, synthesis, and molecular docking. Bioorganic & Medicinal Chemistry Letters 21:2, pages 686-689.
Crossref
Crossref
Aijaz Ahmad, Amber Khan, Luqman Ahmad Khan & Nikhat Manzoor. (2010) In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. Journal of Medical Microbiology 59:10, pages 1178-1184.
Crossref
Crossref
John P. Paluszynski, Roland Klassen & Friedhelm Meinhardt. (2008) Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast. Microbiology 154:10, pages 3154-3164.
Crossref
Crossref
Marina Shalaeva, Jeremy Kenseth, Franco Lombardo & Andrea Bastin. (2008) Measurement of Dissociation Constants (pKa Values) of Organic Compounds by Multiplexed Capillary Electrophoresis Using Aqueous and Cosolvent Buffers**Advanced Analytical Technologies, Inc. (Formerly CombiSep), 2711 South Loop Drive, Suite 4200, Ames, IA 50010.. Journal of Pharmaceutical Sciences 97:7, pages 2581-2606.
Crossref
Crossref
H. Hof. (2008) Will resistance in fungi emerge on a scale similar to that seen in bacteria?. European Journal of Clinical Microbiology & Infectious Diseases 27:5, pages 327-334.
Crossref
Crossref
Priya Uppuluri, Jeniel Nett, Joseph Heitman & David Andes. (2008)
Synergistic Effect of Calcineurin Inhibitors and Fluconazole against
Candida albicans
Biofilms
. Antimicrobial Agents and Chemotherapy 52:3, pages 1127-1132.
Crossref
Crossref
Melanie Legrand, Christine L. Chan, Peter A. Jauert & David T. Kirkpatrick. (2007)
Role of DNA Mismatch Repair and Double-Strand Break Repair in Genome Stability and Antifungal Drug Resistance in
Candida albicans
. Eukaryotic Cell 6:12, pages 2194-2205.
Crossref
Crossref
Á. Medina, M. Jiménez, R. Mateo & N. Magan. (2007) Efficacy of natamycin for control of growth and ochratoxin A production by Aspergillus carbonarius strains under different environmental conditions. Journal of Applied Microbiology 103:6, pages 2234-2239.
Crossref
Crossref
Fedja FarowskiJörg J VehreschildOliver A Cornely. (2007) Posaconazole: a next-generation triazole antifungal. Future Microbiology 2:3, pages 231-243.
Crossref
Crossref
William J. Steinbach, Jennifer L. Reedy, Robert A. Cramer, John R. Perfect & Joseph Heitman. (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nature Reviews Microbiology 5:6, pages 418-430.
Crossref
Crossref
I. S. Mysyakina & N. S. Funtikova. (2007) The role of sterols in morphogenetic processes and dimorphism in fungi. Microbiology 76:1, pages 1-13.
Crossref
Crossref
Lu Yu, Wenliang Zhang, Lingling Wang, Jian Yang, Tao Liu, Junping Peng, Wenchuan Leng, Lihong Chen, Ruoyu Li & Qi Jin. (2007)
Transcriptional Profiles of the Response to Ketoconazole and Amphotericin B in
Trichophyton rubrum
. Antimicrobial Agents and Chemotherapy 51:1, pages 144-153.
Crossref
Crossref
John P. Paluszynski, Roland Klassen, Matthias Rohe & Friedhelm Meinhardt. (2006) Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine inSaccharomyces cerevisiae. Yeast 23:9, pages 707-715.
Crossref
Crossref
Martin Bard, Aaron M. Sturm, Charles A. Pierson, Shaleak Brown, Kristina M. Rogers, Sarah Nabinger, James Eckstein, Robert Barbuch, N.D. Lees, Susan A. Howell & Kevin C. Hazen. (2005) Sterol uptake in Candida glabrata: Rescue of sterol auxotrophic strains. Diagnostic Microbiology and Infectious Disease 52:4, pages 285-293.
Crossref
Crossref
Anita Jandrositz, Julia Petschnigg, Robert Zimmermann, Klaus Natter, Hubert Scholze, Albin Hermetter, Sepp D. Kohlwein & Regina Leber. (2005) The lipid droplet enzyme Tgl1p hydrolyzes both steryl esters and triglycerides in the yeast, Saccharomyces cerevisiae. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1735:1, pages 50-58.
Crossref
Crossref
Hanan K. Munayyer, Paul A. Mann, Andrew S. Chau, Taisa Yarosh-Tomaine, Jonathan R. Greene, Roberta S. Hare, Larry Heimark, Robert E. Palermo, David Loebenberg & Paul M. McNicholas. (2004) Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and Molds. Antimicrobial Agents and Chemotherapy 48:10, pages 3690-3696.
Crossref
Crossref
K. M. Rogers, C. A. Pierson, N. T. Culbertson, C. Mo, A. M. Sturm, J. Eckstein, R. Barbuch, N. D. Lees & M. Bard. (2004)
Disruption of the
Candida albicans CYB5
Gene Results in Increased Azole Sensitivity
. Antimicrobial Agents and Chemotherapy 48:9, pages 3425-3435.
Crossref
Crossref
John W. Baddley & Stephen A. Moser. (2004) Emerging fungal resistance. Clinics in Laboratory Medicine 24:3, pages 721-735.
Crossref
Crossref
Andriani C. Patera, Frederick Menzel, Craig Jackson, Joan K. Brieland, Judy Halpern, Roberta Hare, Anthony Cacciapuoti & David Loebenberg. (2004) Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy 48:8, pages 3154-3158.
Crossref
Crossref
Andrew S. Chau, Cara A. Mendrick, Frank J. Sabatelli, David Loebenberg & Paul M. McNicholas. (2004)
Application of Real-Time Quantitative PCR to Molecular Analysis of
Candida albicans
Strains Exhibiting Reduced Susceptibility to Azoles
. Antimicrobial Agents and Chemotherapy 48:6, pages 2124-2131.
Crossref
Crossref
Marnie M Ford. (2004) Antifungals and their use in veterinary ophthalmology. Veterinary Clinics of North America: Small Animal Practice 34:3, pages 669-691.
Crossref
Crossref
Li Xiao, Vincent Madison, Andrew S. Chau, David Loebenberg, Robert E. Palermo & Paul M. McNicholas. (2004)
Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome P450 14α-Sterol Demethylases from
Aspergillus fumigatus
and
Candida albicans
Provide Insights into Posaconazole Binding
. Antimicrobial Agents and Chemotherapy 48:2, pages 568-574.
Crossref
Crossref
Vlasta Klobučnı́ková, Peter Kohút, Regina Leber, Sandra Fuchsbichler, Natascha Schweighofer, Friederike Turnowsky & Ivan Hapala. (2003) Terbinafine resistance in a pleiotropic yeast mutant is caused by a single point mutation in the ERG1 gene. Biochemical and Biophysical Research Communications 309:3, pages 666-671.
Crossref
Crossref
Chiatogu Onyewu, Jill R. Blankenship, Maurizio Del Poeta & Joseph Heitman. (2003)
Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against
Candida albicans
,
Candida glabrata
, and
Candida krusei
. Antimicrobial Agents and Chemotherapy 47:3, pages 956-964.
Crossref
Crossref
Christine E. Ficker, J. T. Arnason, P. S. Vindas, L. P. Alvarez, K. Akpagana, M. Gbéassor, C. De Souza & M. L. Smith. (2003) Inhibition of human pathogenic fungi by ethnobotanically selected plant extracts. Mycoses 46:1-2, pages 29-37.
Crossref
Crossref
H. Vanden Bossche, M. Engelen & F. Rochette. (2003) Antifungal agents of use in animal health - chemical, biochemical and pharmacological aspects. Journal of Veterinary Pharmacology and Therapeutics 26:1, pages 5-29.
Crossref
Crossref
Juergen Loeffler & David A. Stevens. (2003) Antifungal Drug Resistance. Clinical Infectious Diseases 36:Supplement_1, pages S31-S41.
Crossref
Crossref
Leah E. CowenJames B. AndersonLinda M. Kohn. (2002)
Evolution of Drug Resistance in
Candida Albicans
. Annual Review of Microbiology 56:1, pages 139-165.
Crossref
Crossref
G Inselmann, U Inselmann & H.T Heidemann. (2002) Amphotericin B and liver function. European Journal of Internal Medicine 13:5, pages 288-292.
Crossref
Crossref
Cristina Gil-Lamaignere, Emmanuel Roilides, Juan Mosquera, Avgi Maloukou & Thomas J. Walsh. (2002)
Antifungal Triazoles and Polymorphonuclear Leukocytes Synergize To Cause Increased Hyphal Damage to
Scedosporium prolificans
and
Scedosporium apiospermum
. Antimicrobial Agents and Chemotherapy 46:7, pages 2234-2237.
Crossref
Crossref
N. Jia, B. Arthington-Skaggs, W. Lee, C. A. Pierson, N. D. Lees, J. Eckstein, R. Barbuch & M. Bard. (2002)
Candida albicans
Sterol C-14 Reductase, Encoded by the
ERG24
Gene, as a Potential Antifungal Target Site
. Antimicrobial Agents and Chemotherapy 46:4, pages 947-957.
Crossref
Crossref
Marianne D. De Backer, Patrick Van Dijck & Walter H.M.L. Luyten. (2002) Functional Genomics Approaches for the Identification and Validation of Antifungal Drug Targets. American Journal of PharmacoGenomics 2:2, pages 113-127.
Crossref
Crossref
Maher M. Balkis, Steven D. Leidich, Pranab K. Mukherjee & Mahmoud A. Ghannoum. (2002) Mechanisms of Fungal Resistance. Drugs 62:7, pages 1025-1040.
Crossref
Crossref
Michael E. Klepser. (2012)
Antifungal Resistance Among
Candida
Species
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21:8P2.
Crossref
Crossref
Kora E Aaron, Charles A Pierson, N.Douglas Lees & Martin Bard. (2001)
The
Candida albicans ERG26
gene encoding the C-3 sterol dehydrogenase (C-4 decarboxylase) is essential for growth
. FEMS Yeast Research 1:2, pages 93-101.
Crossref
Crossref
Marianne D. De Backer, Tatiana Ilyina, Xiao-Jun Ma, Sandy Vandoninck, Walter H. M. L. Luyten & Hugo Vanden Bossche. (2001)
Genomic Profiling of the Response of
Candida albicans
to Itraconazole Treatment Using a DNA Microarray
. Antimicrobial Agents and Chemotherapy 45:6, pages 1660-1670.
Crossref
Crossref
Geert Cauwenbergh. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
J. Satyanarayana, H. Situ, S. Narasimhamurthy, N. Bhayani, L.A. Bobek & M.J. Levine. (2000) Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7. The Journal of Peptide Research 56:5, pages 275-282.
Crossref
Crossref
Hongsa Situ & Libuse A. Bobek. (2000) In Vitro Assessment of Antifungal Therapeutic Potential of Salivary Histatin-5, Two Variants of Histatin-5, and Salivary Mucin (MUC7) Domain 1. Antimicrobial Agents and Chemotherapy 44:6, pages 1485-1493.
Crossref
Crossref
Liliete Canes Souza, Paulo Hilário Nascimento Saldiva & Ana Campa. (2000) Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study. Experimental and Toxicologic Pathology 52:2, pages 169-175.
Crossref
Crossref
Russell G. Postier. (2022) Antibiotic-Resistant Organism Infection. The American Surgeon 66:2, pages 112-116.
Crossref
Crossref
Svetlana E. Koshlukova, Tracy L. Lloyd, Marcelo W.B. Araujo & Mira Edgerton. (1999) Salivary Histatin 5 Induces Non-lytic Release of ATP fromCandida albicans Leading to Cell Death. Journal of Biological Chemistry 274:27, pages 18872-18879.
Crossref
Crossref
Jean-Paul Latgé. (1999)
Aspergillus fumigatus
and Aspergillosis
. Clinical Microbiology Reviews 12:2, pages 310-350.
Crossref
Crossref
Lisa J. Green, Philip Marder, Larry L. Mann, Li-Chun Chio & William L. Current. (1999) LY303366 Exhibits Rapid and Potent Fungicidal Activity in Flow Cytometric Assays of Yeast Viability. Antimicrobial Agents and Chemotherapy 43:4, pages 830-835.
Crossref
Crossref
H. Bernhardt, K. Zimmermann & M. Knoke. (1999) Fungal resistance. Infection 27:S2, pages S52-S54.
Crossref
Crossref
H. Tsai & L.A. Bobek. (2016) Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents. Critical Reviews in Oral Biology & Medicine 9:4, pages 480-497.
Crossref
Crossref
P.F. Schweiger & I. Jakobsen. (1998) Dose–response relationships between four pesticides and phosphorus uptake by hyphae of arbuscular mycorrhizas. Soil Biology and Biochemistry 30:10-11, pages 1415-1422.
Crossref
Crossref
Mira Edgerton, Svetlana E. Koshlukova, Thomas E. Lo, Brian G. Chrzan, Robert M. Straubinger & Periathamby A. Raj. (1998) Candidacidal Activity of Salivary Histatins. Journal of Biological Chemistry 273:32, pages 20438-20447.
Crossref
Crossref
K. L. Jensen-Pergakes, M. A. Kennedy, N. D. Lees, R. Barbuch, C. Koegel & M. Bard. (1998)
Sequencing, Disruption, and Characterization of the
Candida albicans
Sterol Methyltransferase (
ERG6
) Gene: Drug Susceptibility Studies in
erg6
Mutants
. Antimicrobial Agents and Chemotherapy 42:5, pages 1160-1167.
Crossref
Crossref
Theodore C. White, Kieren A. Marr & Raleigh A. Bowden. (1998) Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clinical Microbiology Reviews 11:2, pages 382-402.
Crossref
Crossref
H. Vanden Bossche & L. Koymans. (1998) Review Article Cytochromes P450 in fungi. Mycoses 41, pages 32-38.
Crossref
Crossref
D. Gachotte, C. A. Pierson, N. D. Lees, R. Barbuch, C. Koegel & M. Bard. (1997)
A yeast sterol auxotroph (
erg
25) is rescued by addition of azole antifungals and reduced levels of heme
. Proceedings of the National Academy of Sciences 94:21, pages 11173-11178.
Crossref
Crossref
H TsaiL A Bobek. (1997) Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrobial Agents and Chemotherapy 41:10, pages 2224-2228.
Crossref
Crossref
Arlete Emily Cury & Marisa Porta Miche Hirschfeld. (1997)
Interactions between amphotericin B and nitroimidazoles against
Candida albicans
. Mycoses 40:5-6, pages 187-192.
Crossref
Crossref
TC White, MA Pfaller, MG Rinaldi, J Smith & SW Redding. (2013)
Stable azole drug resistance associated with a substrain of
Candida albicans
from an HIV‐infected patient
. Oral Diseases 3:S1.
Crossref
Crossref
S M KirkS M CallisterL C LimR F Schell. (1997) Rapid susceptibility testing of Candida albicans by flow cytometry. Journal of Clinical Microbiology 35:2, pages 358-363.
Crossref
Crossref
David A. Dean & Kenneth W. Burchard. (1996) Fungal infection in surgical patients. The American Journal of Surgery 171:3, pages 374-382.
Crossref
Crossref
A GeberC A HitchcockJ E SwartzF S PullenK E MarsdenK J Kwon-ChungJ E Bennett. (1995) Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrobial Agents and Chemotherapy 39:12, pages 2708-2717.
Crossref
Crossref
Manuka Ghosh & Marvin J. Miller. (1995) Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: Iron transport-mediated drug delivery. Bioorganic & Medicinal Chemistry 3:11, pages 1519-1525.
Crossref
Crossref
M el-SherbeiniJ A Clemas. (1995) Cloning and characterization of GNS1: a Saccharomyces cerevisiae gene involved in synthesis of 1,3-beta-glucan in vitro. Journal of Bacteriology 177:11, pages 3227-3234.
Crossref
Crossref
Martin Fusek, Elizabeth Smith & Stephen I. Foundling. 1995. Aspartic Proteinases. Aspartic Proteinases
489
500
.
M P HaynesH R BuckleyM L HigginsR A Pieringer. (1994) Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers. Antimicrobial Agents and Chemotherapy 38:7, pages 1523-1529.
Crossref
Crossref
Donald R. Kirsch & Beth J. DiDomenico. 1994. Discovery of Novel Natural Products with Therapeutic Potential. Discovery of Novel Natural Products with Therapeutic Potential
177
221
.
G. Cauwenbergh. 1994. Global Dermatology. Global Dermatology
317
330
.
J. L. Tynan, A. J. Conner, R. C. Macknight & R. T. M. Poulter. (1993) Miconazole: An effective antifungal agent for plant tissue culture. Plant Cell, Tissue and Organ Culture 32:3, pages 293-301.
Crossref
Crossref
H. Moereels, H. Vanden Bossche & P. Marichal. 1993. Molecular Biology and its Application to Medical Mycology. Molecular Biology and its Application to Medical Mycology
179
197
.
F. von Bruchhausen, S. Ebel, E. Hackenthal, G. Dannhardt, A. W. Frahm, U. Holzgrabe, K. Keller, E. Nürnberg, H. Rimpler, G. Schneider, P. Surmann, H. U. Wolf & G. Wurm. 1993. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
1057
1220
.
William H. Beggs. (1992) Influence of alkaline pH on the direct lethal action of miconazole againstCandida albicans. Mycopathologia 120:1, pages 11-13.
Crossref
Crossref
David N. Crockett, John F. O'Grady & Peter C. Reade. (1992) Candida species and Candida albicans morphotypes in erythematous candidiasis. Oral Surgery, Oral Medicine, Oral Pathology 73:5, pages 559-563.
Crossref
Crossref
Claude P. Selitrennikoff. 1992. Biotechnology of Filamentous Fungi. Biotechnology of Filamentous Fungi
189
217
.
Johan C. Kapteyn, John B. Pillmoor & Maarten A. De Waard. (2006) Biochemical Mechanisms Involved in Selective Fungitoxicity of Two Sterol 14α‐Demethylation Inhibitors, Prochloraz and Quinconazole: Accumulation and Metabolism Studies. Pesticide Science 36:2, pages 85-93.
Crossref
Crossref
William H. Beggs. (1991) Protonation of ketoconazole in relation to fungistatic activity. Mycopathologia 116:1, pages 3-4.
Crossref
Crossref
S. G. LIM, C. A. LEE, M. HALES, M. O'DOHERTY, M. WINTER & P. B. A. KERNOFF. (2007) Fluconazole for oropharyngeal candidiasis in anti‐HIV positive haemophiliacs. Alimentary Pharmacology & Therapeutics 5:2, pages 199-205.
Crossref
Crossref
R. Prasad. 1991. Candida Albicans. Candida Albicans
108
127
.
H. Vanden Bossche. 1991. Candida Albicans. Candida Albicans
239
257
.
J. Bolard. 1991. Candida Albicans. Candida Albicans
214
238
.
D. R. Kirsch. 1991. Candida Albicans. Candida Albicans
198
213
.
H. Vanden Bossche. 1991. Candida and Candidamycosis. Candida and Candidamycosis
83
95
.
H. Vanden Bossche, P. Marichal, G. Willemsens, D. Bellens, J. Gorrens, I. Roels, M.-C. Coene, L. Le Jeune & P. A. J. Janssen. (1990)
Saperconazole: A selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in
Candida albicans, Aspergillus fumigatus
and
Trichophyton mentagrophytes
. Mycoses 33:7-8, pages 335-352.
Crossref
Crossref
N D Lees, M C Broughton, D Sanglard & M Bard. (1990) Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.. Antimicrobial Agents and Chemotherapy 34:5, pages 831-836.
Crossref
Crossref
Ann B. Orth & Hugh D. Sisler. (1990) Mode of action of terbinafine in Ustilago maydis and characterization of resistant mutants. Pesticide Biochemistry and Physiology 37:1, pages 53-63.
Crossref
Crossref
R. Scott Pore. (1990) Antibiotic susceptibility testing ofCandida albicans by flow cytometry. Current Microbiology 20:5, pages 323-328.
Crossref
Crossref
M.A. Pfaller, J. Riley & T. Koerner. (1990) Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagnostic Microbiology and Infectious Disease 13:1, pages 31-35.
Crossref
Crossref
David Kerridge & Hugo Vanden Bossche. 1990. Chemotherapy of Fungal Diseases. Chemotherapy of Fungal Diseases
31
76
.
H. Vanden Bossche. 1990. Biochemistry of Cell Walls and Membranes in Fungi. Biochemistry of Cell Walls and Membranes in Fungi
135
157
.
M.A. Pfaller & T. Gerarden. (1989) Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents. Diagnostic Microbiology and Infectious Disease 12:6, pages 467-471.
Crossref
Crossref
Hans F. Merk & Hasan Mukhtar. (1989) Azole antifungals. Clinics in Dermatology 7:3, pages 121-127.
Crossref
Crossref
W.H. Beggs. (2009)
Fungistatic Activity of Miconazole against
Candida albicans in
Relation to pH and Concentration of Nonprotonated Drug
. Mycoses 32:5, pages 239-244.
Crossref
Crossref
Norman D. Lees, Frederick W. Kleinhans, M.Christine Broughton, David E. Pennington, veronica A. Ricker & Martin Bard. (1989) Membrane fluidity alterations in a cytochrome P-450-deficient mutant of candida albicans. Steroids 53:3-5, pages 567-578.
Crossref
Crossref
Anil K. Saksena, Viyyoor M. Girijavallabhan, Alan B. Cooper & David Loebenberg. 1989.
111
120
.
Michael A. Gealt, Abbas Abdollahi & Joseph L. Evans. 1989. Current Topics in Medical Mycology. Current Topics in Medical Mycology
218
247
.